Compare

Givaudan SA/Fr. GIVN

1D1W1M3M6MYTD1Y5YMAX

About Givaudan SA

Givaudan SA is a Swiss multinational manufacturer in the fragrance and flavor industry. The company develops fragrances for fine perfumes, personal care products, and household items, alongside flavors for food and beverages. It was founded in 1895 and has been headquartered in Vernier, a suburb of Geneva, Switzerland. Givaudan operates globally with a significant presence in diverse markets, emphasizing innovation in scent and taste experiences. The company's strategic focus includes sustainability and collaboration with clients to create customized solutions, positioning itself strongly in both mature and emerging markets.
Ticker
Fr. GIVN
Sector
Materials
Primary listing
XSWX
Employees
17,508
Headquarters
Vernier, Switzerland
Website
www.givaudan.com

Givaudan SA Metrics

BasicAdvanced
CHF 36B
38.25
CHF 102.71
0.66
CHF 72.00
1.83%

Bulls say / Bears say

Nine-month like-for-like sales growth accelerated to 5.2% from 3.6% at the half year, led by Fragrance & Beauty’s 8.8% growth. This gives the group a strong growth engine even as other areas remain softer. (Givaudan)
Taste & Wellbeing improved through the third quarter: its nine-month growth reached 1.5% like for like, up from 0.5% at the half year. That points to a gradual recovery in a business that had been lagging fragrance. (Givaudan, Givaudan)
Givaudan says it has raised prices with customers to fully offset higher input costs in 2026, helping protect returns if cost inflation persists. Its Microcaps collaboration also adds fragrance technology that could help it win differentiated customer work. (Givaudan, Givaudan)
Taste & Wellbeing remains a weak spot: it grew just 1.5% like for like over nine months, while North American sales fell 3.3%, hurt by weakness in Health and Functional and tariff refunds to customers. Continued underperformance here could weigh on group growth. (Givaudan)
Profitability and cash generation weakened in the first half: adjusted EBITDA margin fell to 24.3% from 25.2%, and adjusted free cash flow was negative CHF 119 million. CHF 103 million of litigation-related and other non-recurring costs also reduced reported profit. (Givaudan)
Currency translation is reducing growth reported in francs: nine-month like-for-like sales rose 5.2%, but sales in Swiss francs increased only 2.6%. A persistently strong franc could keep headline revenue growth well below underlying demand. (Givaudan)
Data summarised monthly by Lightyear AI. Last updated on 13 Oct 2026.

Funds containing Givaudan SA

AllEURUSDGBP
Funds
Fund name
Fund size
Fr. GIVN weighting
iShares STOXX Europe 600 Chemicals€EXV7
€103M14.51%
SPDR MSCI World Materials€WMAT
$206M1.52%
iShares MSCI Europe SRI£IESG
€3.2B1.29%
iShares MSCI Europe SRI€IESE
€3.2B1.29%
iShares MSCI Europe ESG Enhanced€EMNU
€4.9B1.16%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.